Hyperthermia suppresses the cytotoxicity of NK cells via down-regulation of perforin/granzyme B expression

被引:17
作者
Koga, T
Harada, H
Shi, TS
Okada, S
Suico, MA
Shuto, T
Kai, H
机构
[1] Kumamoto Univ, Dept Mol Med, Fac Med & Pharmaceut Sci, Kumamoto 8620973, Japan
[2] Kumamoto Univ, Div Hematopoiesis, Ctr AIDS Res, Kumamoto 8600811, Japan
关键词
whole body hyperthermia; NK cells; perforin; granzyme B; FasL/TRAIL; infrared box; Rag-2 knockout mouse;
D O I
10.1016/j.bbrc.2005.09.184
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hyperthermia. which is used as an adjunctive therapy for cancer, is known to modulate the activity of natural killer (NK) cells in vitro, but its effect in vivo is unclear. In the present study, we used a whole body hyperthermia (WBH) device heated by infrared rays to evaluate the effect of WBH on mice models. We demonstrate here that wild type C57BL/6J mice exposed to 42 degrees C for 60 min had reduced NK cell cytolytic activity against YAC-1 target cells as determined by cytolytic assay. This result was confirmed using Rag-2 knockout mice, which possess functional NK but not cytolytic T or NK-T cells. Moreover, WBH decreased the mRNA expression of perform and granzyme B in spleens of mice. But the expression of TNF cytokines (Fas ligand and TRAIL) was unchanged. These data suggest that the suppression of NK cell activity induced by WBH Could be mediated through the perforin/granzyme pathway. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1319 / 1323
页数:5
相关论文
共 34 条
[1]  
BARLOZZARI T, 1983, J IMMUNOL, V131, P1024
[2]  
Burd R, 1998, J CELL PHYSIOL, V177, P137, DOI 10.1002/(SICI)1097-4652(199810)177:1<137::AID-JCP15>3.0.CO
[3]  
2-A
[4]   The treatment of malignancy by hyperthermia [J].
Christophi, C ;
Winkworth, A ;
Muralihdaran, V ;
Evans, P .
SURGICAL ONCOLOGY-OXFORD, 1998, 7 (1-2) :83-90
[5]  
DOWNING JF, 1987, LYMPHOKINE RES, V6, P103
[6]  
Fuggetta MP, 2000, ANTICANCER RES, V20, P1667
[7]  
GORELIK E, 1984, J NATL CANCER I, V72, P1397
[8]   The cellular and molecular basis of hyperthermia [J].
Hildebrandt, B ;
Wust, P ;
Ahlers, O ;
Dieing, A ;
Sreenivasa, G ;
Kerner, T ;
Felix, R ;
Riess, H .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2002, 43 (01) :33-56
[9]  
IZUMI A, 1983, CANCER-AM CANCER SOC, V51, P2061, DOI 10.1002/1097-0142(19830601)51:11<2061::AID-CNCR2820511118>3.0.CO
[10]  
2-2